IRONWOOD PHARMACEUTICALS, INC. Cash and Cash Equivalents
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Cash and Cash Equivalents of $79.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $79.13M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $220.47M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $215.46M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $140.41M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $79.13M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $220.47M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $215.46M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $140.41M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $92.85M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $108.48M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $88.56M 10-K · filed 2026-02-26 |
| 2024-09-30 | $88.21M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $105.52M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $121.54M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $92.15M 10-K · filed 2025-03-31 |
| 2023-09-30 | $110.16M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $175.32M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $740.34M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $656.20M 10-K · filed 2025-03-31 |
| 2022-09-30 | $574.19M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $504.37M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $593.37M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $620.13M 10-K · filed 2024-02-16 |
| 2021-09-30 | $574.28M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $492.70M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $438.47M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $362.56M 10-K · filed 2023-02-16 |
| 2020-09-30 | $307.56M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $253.25M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $231.14M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $177.02M 10-K · filed 2022-02-18 |
| 2019-09-30 | $139.23M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $98.91M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $119.05M 10-Q · filed 2020-05-06 |
| 2018-12-31 | $173.17M 10-K · filed 2021-02-17 |
| 2018-09-30 | $141.56M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $145.41M 10-Q · filed 2019-07-30 |
| 2018-03-31 | $144.79M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $125.74M 10-K · filed 2020-02-13 |
| 2017-09-30 | $162.64M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $182.13M 10-Q · filed 2018-08-06 |
| 2017-03-31 | $133.32M 10-Q · filed 2018-05-04 |
| 2016-12-31 | $54.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $182.94M 10-Q · filed 2017-11-02 |
| 2016-06-30 | $277.33M 10-Q · filed 2017-08-03 |
| 2016-03-31 | $280.93M 10-Q · filed 2017-05-08 |
| 2015-12-31 | $261.29M 10-K · filed 2018-02-22 |
| 2015-09-30 | $248.08M 10-Q · filed 2016-11-07 |
| 2015-06-30 | $256.45M 10-Q · filed 2016-08-08 |
| 2015-03-31 | $63.69M 10-Q · filed 2016-05-10 |
| 2014-12-31 | $74.30M 10-K · filed 2018-02-22 |
| 2014-09-30 | $51.27M 10-Q · filed 2015-11-05 |
| 2014-06-30 | $95.36M 10-Q · filed 2015-08-07 |
| 2014-03-31 | $205.13M 10-Q · filed 2015-05-06 |
| 2013-12-31 | $75.49M 10-K · filed 2017-02-22 |
| 2013-09-30 | $144.45M 10-Q · filed 2014-11-05 |
| 2013-06-30 | $219.46M 10-Q · filed 2014-08-05 |
| 2013-03-31 | $105.30M 10-Q · filed 2014-04-29 |
| 2012-12-31 | $136.70M 10-K · filed 2016-02-19 |
| 2012-09-30 | $125.87M 10-Q · filed 2013-10-28 |
| 2012-06-30 | $87.08M 10-Q · filed 2013-08-08 |
| 2012-03-31 | $131.61M 10-Q · filed 2013-04-23 |
| 2011-12-31 | $87.28M 10-K · filed 2015-02-18 |
| 2011-09-30 | $68.82M 10-Q · filed 2012-11-06 |
| 2011-06-30 | $48.19M 10-Q · filed 2012-08-07 |
| 2011-03-31 | $46.21M 10-Q · filed 2012-05-10 |
| 2010-12-31 | $44.32M 10-K · filed 2014-02-07 |
| 2010-09-30 | $58.70M 10-Q · filed 2011-11-09 |
| 2010-06-30 | $35.36M 10-Q · filed 2011-08-12 |
| 2009-12-31 | $122.31M 10-K · filed 2013-02-21 |
| 2008-12-31 | $66.33M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |